HUYA Bioscience International Further Expands Executive Team

Appoints Gloria Tsi-Yie Lee, M.D., Ph.D., as Chief Medical Officer

San Diego, CA, USA – September 15, 2015 –HUYA Bioscience International (HUYA) today announced the expansion of its Executive Team with the appointment of Gloria Tsi-Yie Lee, M.D., Ph.D., as Chief Medical Officer.

Read more

HUYA Bioscience International Announces Epigenetic Breast Cancer Program

Expansion marked by clinical development for multiple HER2 subtypes of breast cancer

San Diego, CA, USA – September 3, 2015 –HUYA Bioscience International (HUYA) today announced expanding clinical trials with its lead cancer drug, HBI-8000, starting with a Phase 1 combination trial in support of a breast cancer program to be conducted in the United States.

Read more